Compare Stocks

→ He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACST Acasti Pharma	$2.94 +2.1%	$3.33	$1.72 ▼ $3.84	$27.63M	1.49	26,275 shs	8,422 shs
EMH Emerald Health Therapeutics	C$0.26 -3.8%	C$0.26	C$0.15 ▼ C$0.53	C$52.28M	N/A	644,760 shs	384,329 shs
MVF BlackRock MuniVest Fund	$6.80 -0.1%	$6.97	$5.85 ▼ $7.19	$437.92M	0.46	158,824 shs	123,362 shs

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACST Acasti Pharma	+1.05%	-14.54%	-15.29%	+19.50%	+0.13%
EMH Emerald Health Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%
MVF BlackRock MuniVest Fund	0.00%	+0.52%	-2.99%	-0.73%	+0.44%

A new way to collect income from stocks (Ad)

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ACST Acasti Pharma	2.5315 of 5 stars	3.5	5.0	0.0	0.0	0.6	0.8	1.3
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MVF BlackRock MuniVest Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACST Acasti Pharma	3.00	Buy	$6.00	104.08% Upside
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A
MVF BlackRock MuniVest Fund	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest MVF, HZD, ACST, and EMH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
2/7/2024	ACST Acasti Pharma	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$6.00

(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACST Acasti Pharma	N/A	N/A	N/A	N/A	$9.14 per share	N/A
EMH Emerald Health Therapeutics	C$13.02M	4.02	C$0.33 per share	0.78	C$0.40 per share	0.64
MVF BlackRock MuniVest Fund	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACST Acasti Pharma	-$42.43M	-$5.08	N/A	N/A	N/A	N/A	-13.18%	-11.32%	6/28/2024 (Estimated)
EMH Emerald Health Therapeutics	N/A	-C$0.70	N/A	∞	N/A	N/A	N/A	N/A	N/A
MVF BlackRock MuniVest Fund	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest MVF, HZD, ACST, and EMH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/12/2024	12/31/2023	ACST Acasti Pharma	-$0.23	-$0.21	+$0.02	-$0.21	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACST Acasti Pharma	N/A	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A
MVF BlackRock MuniVest Fund	$0.30	4.41%	N/A	N/A	N/A

Latest MVF, HZD, ACST, and EMH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/1/2024	MVF BlackRock MuniVest Fund	monthly	$0.03	5.2%	4/12/2024	4/15/2024	5/1/2024
3/1/2024	MVF BlackRock MuniVest Fund	monthly	$0.03	5.1%	3/14/2024	3/15/2024	4/1/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACST Acasti Pharma	N/A	15.19	15.19
EMH Emerald Health Therapeutics	35.45	2.97	2.61
MVF BlackRock MuniVest Fund	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ACST Acasti Pharma	6.08%
EMH Emerald Health Therapeutics	N/A
MVF BlackRock MuniVest Fund	48.16%

Insider Ownership

Company	Insider Ownership
ACST Acasti Pharma	13.51%
EMH Emerald Health Therapeutics	N/A
MVF BlackRock MuniVest Fund	1.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ACST Acasti Pharma	32	9.40 million	8.13 million	Not Optionable
EMH Emerald Health Therapeutics	161	205.03 million	N/A	Not Optionable
MVF BlackRock MuniVest Fund	147,000	64.40 million	63.75 million	Not Optionable

MVF, HZD, ACST, and EMH Headlines

Source	Headline
	Allspring Global Investments Holdings LLC Boosts Stock Holdings in BlackRock MuniVest Fund, Inc. (NYSE:MVF) marketbeat.com - April 17 at 5:01 AM
	BlackRock MuniVest Fund, Inc. (NYSE:MVF) Short Interest Update marketbeat.com - April 11 at 5:44 PM
	BlackRock MuniVest Fund, Inc. Announces Monthly Dividend of $0.03 (NYSE:MVF) marketbeat.com - April 3 at 5:19 PM
	BlackRock MuniVest declares $0.03 dividend msn.com - March 4 at 2:34 PM
	BlackRock Advantage SMID Cap Fund;Investor A wsj.com - March 2 at 12:56 AM
	BlackRock High Equity Income Fund;Investor C wsj.com - February 24 at 1:12 PM
	BlackRock MuniVest Fund II raises dividend by 60.3% msn.com - November 16 at 5:45 PM
	BlackRock Impact Mortgage Fund;Investor A wsj.com - August 26 at 5:17 AM
	BlackRock Advantage Large Cap Value Fund;Investor A wsj.com - August 9 at 8:06 PM
	BlackRock MuniVest Fund, Inc money.usnews.com - July 25 at 8:38 AM
	BlackRock MuniVest Fund II declares $0.0315 dividend msn.com - June 2 at 3:50 PM
	MVF - BlackRock MuniVest Fund, Inc. finance.yahoo.com - May 31 at 3:08 PM
	Blackrock Munivest Fund Stock (NYSE:MVF), Dividends benzinga.com - May 11 at 5:00 AM
	BlackRock MuniVest declares $0.021 dividend msn.com - May 9 at 5:23 PM
	BlackRock Equity Dividend Fund;Institutional wsj.com - March 26 at 12:54 AM
	BlackRock Emerging Markets Fund;Investor C wsj.com - March 23 at 2:22 PM
	BlackRock MuniVest Fund declares $0.021 dividend msn.com - January 6 at 7:40 PM
	AT&T, BlackRock to form commercial fibre-optic platform businesstimes.com.sg - December 26 at 3:17 PM
	Wednesday Is Your Last Chance To Buy Blackrock Munivest Fund Before The Dividend Payout msn.com - December 12 at 6:26 PM
	BlackRock 60/40 Target Allocation Inv A morningstar.com - November 30 at 10:05 AM
	Blackrock Munivest Fund II (NYSE: MVT) fool.com - October 29 at 12:14 AM
	BlackRock Hopes Investors Rediscover the Joy of Bonds wsj.com - October 16 at 9:36 PM
	Republican treasurers withdraw $1B from BlackRock over ESG investments nypost.com - October 13 at 11:40 PM
	BlackRock says markets will get 'Fed up' with too much tightening as growth slows, with Powell showing the most resolve since Paul Volcker markets.businessinsider.com - September 28 at 12:32 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Acasti Pharma

NASDAQ:ACST

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Emerald Health Therapeutics

CVE:EMH

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

BlackRock MuniVest Fund

NYSE:MVF

BlackRock MuniVest Fund, Inc. is a closed-ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in the fixed income markets of the United States. It primarily invests in investment grade, long term municipal obligations that are exempt from federal income taxes. The fund seeks to invest in securities with maturities of more than ten years. BlackRock MuniVest Fund, Inc. was formed on September 29, 1988 and is domiciled in the United States.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial